{"acute graft versus host disease": 63.47, "acute kidney injury": 2.64, "acute myeloid leukaemia": 9.18, "adenovirus infection": 65.19, "anaemia": 2.08, "cytomegalovirus infection": 12.58, "cytomegalovirus infection reactivation": 29.94, "febrile neutropenia": 24.96, "haemophagocytic lymphohistiocytosis": 18.52, "incorrect route of product administration": 4.98, "mucosal inflammation": 38.22, "multiple organ dysfunction syndrome": 7.38, "myelodysplastic syndrome": 17.93, "neuropathy peripheral": 4.66, "neutropenia": 5.54, "off label use": 5.77, "pancytopenia": 9.2, "plasma cell myeloma": 21.66, "pleural effusion": 3.43, "product use in unapproved indication": 3.2, "respiratory failure": 4.04, "retinal degeneration": 98.55, "sepsis": 3.1, "septic shock": 6.81, "stomatitis": 5.4, "thrombocytopenia": 3.99, "thrombotic microangiopathy": 39.99, "venoocclusive liver disease": 79.02}